Generative AI Leap: Insilico Medicine Nominates First Preclinical Candidate in the UAE

Generative AI Leap: Insilico Medicine Nominates First Preclinical Candidate in the UAE

For its 30th PCC anniversary, Insilico Medicine nominated ISM0387, the first UAE-based preclinical candidate, jointly announced with the Emirates Drug Establishment (EDE), with the support of local partners including Abu Dhabi Investment Office...

WiMi announced a net income of RMB 347 million for 2025, a year-on-year increase of 235%

WiMi announced a net income of RMB 347 million for 2025, a year-on-year increase of 235%

BEIJING, April 24, 2026 /PRNewswire/ -- WiMi Hologram Cloud Inc. (Nasdaq: WIMI) ("WiMi" or the "Company"), a leading hologram augmented reality ("AR") technology provider, today announced that it has filed its annual report on Form 20-F for the...

Electrolux Group Interim report Q1 2026

Electrolux Group Interim report Q1 2026

STOCKHOLM, April 24, 2026 /PRNewswire/ -- Highlights of the first quarter of 2026 Net sales amounted to SEK 29,543m (32,576) with flat organic sales of -0.5% (7.9). Organic sales growth was +3.6% in Europe, Middle East & Africa and Asia Pacific...

SnapInspect Now Fully Qualified Yardi® Ecosystem Partner

SnapInspect Now Fully Qualified Yardi® Ecosystem Partner

Interface is available now to SnapInspect clients using Yardi Voyager® DALLAS, April 24, 2026 /PRNewswire/ -- SnapInspect today announced it is now a fully qualified Yardi® Standard Interface Vendor, joining the approved network for Yardi, the...

Historic Artworks Receive Funding through BofA's Art Conservation Project™

Historic Artworks Receive Funding through BofA's Art Conservation Project™

Spanning 10 countries, the 2026 selections highlight the program's global commitment to art conservation Key Points Bank of America is awarding 18 Art Conservation Project™ grants to preserve significant artworks in 2026. This year's projects...

Starti AI Studio Upgrades to 2.0: From Video Generation Tool to Complete Advertising Creative System

Starti AI Studio Upgrades to 2.0: From Video Generation Tool to Complete Advertising Creative System

PALO ALTO, Calif., April 24, 2026 /PRNewswire/ -- Starti.ai, a technology company developing AI-powered tools for advertising video production, has announced the release of AI Studio 2.0, a system-level upgrade to its flagship platform. The update...

NEW YORK'S SIP & GUZZLE IS NAMED THE BEST BAR IN NORTH AMERICA AT NORTH AMERICA'S 50 BEST BARS 2026

NEW YORK'S SIP & GUZZLE IS NAMED THE BEST BAR IN NORTH AMERICA AT NORTH AMERICA'S 50 BEST BARS 2026

VANCOUVER, BC, April 23, 2026 /PRNewswire/ -- Sip & Guzzle in New York City named The Best Bar in North America at North America’s 50 Best Bars 2026, sponsored by Perrier, at a live awards ceremony in Vancouver, Canada, on April 22. Sip &...

MetaOptics achieves a progressive milestone in securing design/evaluation orders for its metalenses and modules from world-class customers

MetaOptics achieves a progressive milestone in securing design/evaluation orders for its metalenses and modules from world-class customers

SINGAPORE, April 23, 2026 /PRNewswire/ -- MetaOptics Ltd (Catalist: 9MT) ("MetaOptics" or the "Company", and together with its subsidiaries, the "Group") is pleased to announced that it has achieved a progressive milestone in securing...

OpenAI's GPT Image 2 Is Now Available on Pollo AI

OpenAI's GPT Image 2 Is Now Available on Pollo AI

SINGAPORE, April 22, 2026 /PRNewswire/ -- Pollo AI today announced the availability of OpenAI's GPT Image 2 on its platform, giving creators, marketers, and businesses access to a stronger image model for work that depends on getting details right....

2026 ASCO Preview | Results from Phase III Study of Anbenitamab (KN026) Combined with HB1801 in Neoadjuvant Treatment for Breast Cancer Selected for LBA Oral Presentation

2026 ASCO Preview | Results from Phase III Study of Anbenitamab (KN026) Combined with HB1801 in Neoadjuvant Treatment for Breast Cancer Selected for LBA Oral Presentation

SUZHOU, China, April 22, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced that the significant results from the Phase III clinical study (KN026-004) of HER2 bispecific antibody Anbenitamab Injection (KN026), independently...

  • 1
  • ...
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • ...
  • 275
  • menu
    menu